| AJCC | American Joint Committee on Cancer |
| AIC | Akaike information criterion |
| BRAF | B-rapidly accelerated fibrosarcoma |
| CI | Confidence interval |
| CDR3 | Complementarity determining region 3 |
| CPTAC | Clinical Proteomic Tumor Analysis Consortium |
| CRC | Colorectal cancer |
| EGFR | Epidermal growth factor receptor |
| HR | Hazard ratio |
| ICIs | Immune checkpoint inhibitors |
| MANTIS | Microsatellite analysis for normal-tumor instability |
| MMRd | Mismatch repair-deficient |
| MMRp | Mismatch repair-proficient |
| MSI | Microsatellite instable |
| MSS | Microsatellite stable |
| OS | Overall survival |
| PD-L1 | Programmed death ligand 1 |
| REMARK | REporting recommendations for tumour MARKer prognostic studies |
| SBS | Single-base substitution |
| SNV | Single-nucleotide variation |
| TCGA | The Cancer Genome Atlas |
| TCR | T-cell receptor |
| TILs | Tumour-infiltrating lymphocytes |
| TIL/Tc | Tumour-infiltrating lymphocyte T cells |
| TMB | Tumour mutational burden |
| TNM | Tumour–Node–Metastasis |
| UICC | Union for International Cancer Control |
| VELIPI | Vascular emboli, lymphatic invasion, perineural invasion |